{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T17:51:11Z","timestamp":1795024271529,"version":"4.10.2"},"reference-count":33,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1038\/s41379-022-01052-4","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T06:06:11Z","timestamp":1646633171000},"page":"858-864","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?"],"prefix":"10.1016","volume":"35","author":[{"given":"Mohammed Amer","family":"Swid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E.","family":"Monaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/s41379-022-01052-4_bib1","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/v10120729","article-title":"Cervical cancer screening programs in Europe: The transition towards HPV vaccination and population-based HPV testing","volume":"10","author":"Chrysostomou","year":"2018","journal-title":"Viruses"},{"key":"10.1038\/s41379-022-01052-4_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/dc.21226","article-title":"What's in a name? Evidence that Papanicolaou, not Babes, deserves credit for the Pap test","volume":"38","author":"Diamantis","year":"2010","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/s41379-022-01052-4_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ajog.2015.10.147","article-title":"Cervical cancer screening: evidence behind the guidelines","volume":"214","author":"Lees","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1038\/s41379-022-01052-4_bib4","doi-asserted-by":"crossref","first-page":"720","DOI":"10.21147\/j.issn.1000-9604.2020.06.05","article-title":"Cervical cancer: epidemiology, risk factors and screening","volume":"32","author":"Chang","year":"2020","journal-title":"Chin J Cancer Res"},{"key":"10.1038\/s41379-022-01052-4_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ygyno.2018.10.004","article-title":"Too many women are dying from cervix cancer: problems and solutions","volume":"151","author":"Gaffney","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1038\/s41379-022-01052-4_bib6","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/cncr.30667","article-title":"Cervical cancer: A global health crisis","volume":"123","author":"Small","year":"2017","journal-title":"Cancer"},{"key":"10.1038\/s41379-022-01052-4_bib7","unstructured":"NIH. HPV and Pap Testing. [Internet] December 20, 2019 [cited 01 November 2021]. Available from https:\/\/www.cancer.gov\/types\/cervical\/pap-hpv-testing-fact-sheet."},{"key":"10.1038\/s41379-022-01052-4_bib8","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ygyno.2017.06.003","article-title":"Why does cervical cancer occur in a state-of-the-art screening program?","volume":"146","author":"Castle","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1038\/s41379-022-01052-4_bib9","first-page":"441","article-title":"Cervical cancer screening","volume":"97","author":"Rerucha","year":"2018","journal-title":"Am Fam Physician"},{"key":"10.1038\/s41379-022-01052-4_bib10","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3322\/caac.21628","article-title":"Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society","volume":"70","author":"Fontham","year":"2020","journal-title":"Cancer J Clin"},{"key":"10.1038\/s41379-022-01052-4_bib11","unstructured":"USPSTF Cervical Cancer: Screening, [Internet] August 21, 2018, [cited 01 November 2021]. Available from www.uspreventiveservicestaskforce.org\/uspstf\/recommendation\/cervical-cancer-screening."},{"issue":"Suppl 1","key":"10.1038\/s41379-022-01052-4_bib12","first-page":"S2","article-title":"The impact of liquid-based cytology in decreasing the incidence of cervical cancer","volume":"4","author":"Gibb","year":"2011","journal-title":"Rev Obstet Gynecol"},{"key":"10.1038\/s41379-022-01052-4_bib13","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1001\/jama.2009.1569","article-title":"Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial","volume":"302","author":"Siebers","year":"2009","journal-title":"JAMA"},{"key":"10.1038\/s41379-022-01052-4_bib14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/dc.20118","article-title":"Pap test in a high-risk population comparison of conventional and liquid-base cytology","volume":"31","author":"Utagawa","year":"2004","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/s41379-022-01052-4_bib15","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cncr.22953","article-title":"Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program: a prospective randomized study","volume":"111","author":"Strander","year":"2007","journal-title":"Cancer"},{"key":"10.1038\/s41379-022-01052-4_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.AOG.0000296488.85807.b3","article-title":"Liquid compared with conventional cervical cytology: a systematic review and meta-analysis","volume":"111","author":"Arbyn","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1038\/s41379-022-01052-4_bib17","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/cncy.20081","article-title":"Accuracy of liquid-based cytology: comparison of the results obtained within a randomized controlled trial (the New Technologies for Cervical Cancer Screening Study) and an external group of experts","volume":"118","author":"Confortini","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.1038\/s41379-022-01052-4_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/ajcp\/aqy114","article-title":"Enhanced detection of cervical cancer and precancer through use of imaged liquid-based cytology in routine cytology and HPV cotesting","volume":"150","author":"Austin","year":"2018","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-022-01052-4_bib19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1111\/j.1471-0528.2011.03228.x","article-title":"Cost-effectiveness of cervical cancer screening: cytology versus human papillomavirus DNA testing","volume":"119","author":"van Rosmalen","year":"2012","journal-title":"BJOG"},{"key":"10.1038\/s41379-022-01052-4_bib20","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JCM.01087-15","article-title":"Point-counterpoint: cervical cancer screening should be done by primary human papillomavirus testing with genotyping and reflex cytology for women over the age of 25 years","volume":"53","author":"Stoler","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1038\/s41379-022-01052-4_bib21","doi-asserted-by":"crossref","first-page":"100206","DOI":"10.1016\/j.pvr.2020.100206","article-title":"CINtec PLUS and cobas HPV testing for triaging Canadian women referred to colposcopy with a history of low-grade squamous intraepithelial lesion: Baseline findings","volume":"10","author":"Ratnam","year":"2020","journal-title":"Papillomavirus Res"},{"key":"10.1038\/s41379-022-01052-4_bib22","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/ajcp\/aqaa074","article-title":"Contributions of liquid-based (Papanicolaou) cytology and human papillomavirus testing in cotesting for detection of cervical cancer and precancer in the United States","volume":"154","author":"Kaufman","year":"2020","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-022-01052-4_bib23","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/jnci\/djj209","article-title":"Human papillomavirus testing and liquid-based cytology: results at recruitment from the new technologies for cervical cancer randomized controlled trial","volume":"98","author":"Ronco","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1038\/s41379-022-01052-4_bib24","doi-asserted-by":"crossref","unstructured":"Chelmow, D. & ACOG. Practice Bulletin No. 168: Cervical cancer screening and prevention. Obstet Gynecol 128, e111\u2013e130 (2016).","DOI":"10.1097\/AOG.0000000000001708"},{"key":"10.1038\/s41379-022-01052-4_bib25","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/dc.23959","article-title":"High grade squamous intraepithelial lesion on high-risk HPV negative patients: Why we still need the Pap test","volume":"46","author":"Sun","year":"2018","journal-title":"Diagn Cytopathol"},{"key":"10.1038\/s41379-022-01052-4_bib26","first-page":"3117","article-title":"Prevalence of abnormal pap smears: a descriptive study from a cancer center in a low-prevalence community","volume":"18","author":"Maraqa","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1038\/s41379-022-01052-4_bib27","first-page":"69","article-title":"Abnormal Pap smear frequency and comparison of repeat cytological follow-up with colposcopy during patient management: the importance of pathologist's guidance in the management","volume":"6","author":"Arslan","year":"2019","journal-title":"North Clin Istanb"},{"key":"10.1038\/s41379-022-01052-4_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1093\/ajcp\/aqaa169","article-title":"Cotesting in cervical cancer screening","volume":"155","author":"Malinowski","year":"2021","journal-title":"Am J Clin Pathol"},{"key":"10.1038\/s41379-022-01052-4_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.ajog.2012.11.020","article-title":"Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16\/18: results from the ATHENA HPV study","volume":"208","author":"Cox","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1038\/s41379-022-01052-4_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jasc.2018.08.005","article-title":"An advocacy victory: final USPSTF cervical cancer screening recommendations revised to include cotesting option","volume":"7","author":"Davey","year":"2018","journal-title":"J Am Soc Cytopathol"},{"key":"10.1038\/s41379-022-01052-4_bib31","unstructured":"ASC Position Statement on Cervical Cancer Screening, [Internet] 2019, [cited 10 January 2022]. Available from https:\/\/cdn.ymaws.com\/cytopathology.org\/resource\/collection\/FBE5C718-392A-4803-B7A1-7DA9732065BB\/Cervical_Cancer_Screening_and_Prevention_Position_Statement_8.28.pdf."},{"key":"10.1038\/s41379-022-01052-4_bib32","unstructured":"USPTF Draft Research Plan. Cervical Cancer: Screening, [Internet] 2021, [cited 10 January 2022]. Available from https:\/\/uspreventiveservicestaskforce.org\/uspstf\/document\/draft-research-plan\/cervical-cancer-screening-adults-adolescents."},{"key":"10.1038\/s41379-022-01052-4_bib33","doi-asserted-by":"crossref","first-page":"2921914","DOI":"10.17061\/phrp2921914","article-title":"Lessons from the renewal of the National Cervical Screening Program in Australia","volume":"29","author":"Smith","year":"2019","journal-title":"Public Health Res Pract"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01052-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01052-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222000758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222000758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41379-022-01052-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T00:28:20Z","timestamp":1760228900000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222000758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":33,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S0893395222000758"],"URL":"https:\/\/doi.org\/10.1038\/s41379-022-01052-4","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should screening for cervical cancer go to primary human papillomavirus testing and eliminate cytology?","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/s41379-022-01052-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}